Pulmonary hypertension Historical Perspective: Difference between revisions
(Page Creation/Layout) |
|||
| Line 6: | Line 6: | ||
==Historical Perspective== | ==Historical Perspective== | ||
The incidence of PAH associated with anorexigens is cyclical in nature and varies depending on the availability of specific appetite suppressants. The link was first identified in the 1960s when an epidemic of PAH occurred in Switzerland, Austria and Germany that was linked to the anorexigen aminorex fumarate. Use of the anorexigens fenfluramine and dexfenfluramine have also been linked with an increased risk for PAH. | |||
==References== | ==References== | ||
Revision as of 18:34, 1 March 2018
|
Pulmonary Hypertension Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pulmonary hypertension Historical Perspective On the Web |
|
American Roentgen Ray Society Images of Pulmonary hypertension Historical Perspective |
|
Risk calculators and risk factors for Pulmonary hypertension Historical Perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
The incidence of PAH associated with anorexigens is cyclical in nature and varies depending on the availability of specific appetite suppressants. The link was first identified in the 1960s when an epidemic of PAH occurred in Switzerland, Austria and Germany that was linked to the anorexigen aminorex fumarate. Use of the anorexigens fenfluramine and dexfenfluramine have also been linked with an increased risk for PAH.